# OnCo record mrt-2359 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/mrt-2359/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "mrt-2359" ;
  schema:name "MRT-2359"@en ;
  schema:description "MRT-2359 is an experimental oral molecular glue degrader from Monte Rosa Therapeutics, in phase 2 trials for castration-resistant prostate cancer."@en ;
  schema:url <https://onco.cc/drugs/mrt-2359/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.monterosatx.com/pipeline/>, <https://www.monterosatx.com/pipeline/>, <https://www.monterosatx.com/pipeline/>, <https://clinicaltrials.gov/api/v2/studies/NCT07745361>, <https://clinicaltrials.gov/search?intr=MRT-2359> ;
  onco:status "phase-2" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Oral molecular glue degrader" ;
  onco:cancers <https://onco.cc/cancers/prostate-mcrpc/> ;
  onco:companies <https://onco.cc/companies/monte-rosa/> ;
  onco:trials <https://onco.cc/trials/nct07745361/>, <https://onco.cc/trials/nct05546268/> .